A Major Step Forward in Donning, Fit, and Function – Enhancing User Independence
Myomo, Inc. , a wearable medical robotics company that offers improved arm and hand function for individuals with upper-limb paralysis and neuromuscular conditions, announced the launch of the MyoPro 2x, the latest evolution in its flagship MyoPro product line.
Designed to enhance the user experience, the MyoPro 2x introduces a reimagined approach to donning, empowering users with a more intuitive, efficient, and consistent process to independently put on their device, while improving fit and function, which is expected to lead to enhanced clinical outcomes.
Health Technology Insights: Kavira Health Expands to Fargo via Partnership with Red River Valley Health Plan
“Our goals for these enhancements were primarily clinical. The product development process was driven by inputs from users and clinicians, along with Myomo’s own product performance data. This patient and clinician focus was generated from the knowledge gained from over 3000 patients who have received a MyoPro,” said Malcolm Bock, Myomo’s V.P. Engineering and Product Strategy. “The MyoPro 2x is our best product yet, and we are excited for the significant patient impact of this launch.”
Highlights of the MyoPro 2x include streamlined and more intuitive donning for a consistent fit for the patient, integrating common customizations into the standard design in order to decrease the time for clinicians to fit the MyoPro 2x to their individual patients, and updated training documentation and instruction guides for treating practitioners and users.
Health Technology Insights: CMS Grants Fresenius Kabi Permanent, Product-Specific Q-Code for Otulfi
Supporting today’s launch, Myomo recently rolled out their full certification process for Orthotic & Prosthetic providers to become MyoPro Centers of Excellence to focus on the MyoPro 2x. This process empowers practices to build their own patient pipelines and, once fully certified, to treat patients with the technology and dispense the MyoPro 2x independently.
“The MyoPro 2x is about more than innovation—it’s about putting independence back into the hands of users,” said Paul R. Gudonis, Chairman and CEO of Myomo. “This launch is the result of our commitment to listen to clinicians and users alike and to deliver meaningful improvements that make a real difference in daily life. The MyoPro 2x furthers our leadership in this new and growing space.”
Health Technology Insights: Lutris Pharma Appoints Life Sciences Veteran Sumant Ramachandra as CEO
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – businesswire
